scispace - formally typeset
J

Johannes R. Bogner

Researcher at Ludwig Maximilian University of Munich

Publications -  297
Citations -  9070

Johannes R. Bogner is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Viral load & Cytotoxic T cell. The author has an hindex of 38, co-authored 281 publications receiving 8394 citations. Previous affiliations of Johannes R. Bogner include Klinikum der Universität München.

Papers
More filters
Journal ArticleDOI

Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

Daniel D Murray, +1489 more
- 14 Oct 2015 - 
TL;DR: No associations with mortality were found with any circulating miRNAs studied and these results cast doubt onto the effectiveness of circulating miRNA as early predictors of mortality or the major underlying diseases that contribute to mortality in participants treated for HIV-1 infection.
Journal ArticleDOI

Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

Alison Rodger, +168 more
- 15 Jun 2019 - 
TL;DR: The results suggest that the risk of HIV transmission in gay couples through condomless sex when HIV viral load is suppressed is effectively zero, which supports the message of the U=U (undetectable equals untransmittable) campaign, and the benefits of early testing and treatment for HIV.
Journal ArticleDOI

Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients

TL;DR: There is a large variation in the severity and clinical presentation of protease inhibitor-associated metabolic side-effects, leading to impaired or diabetic oral glucose tolerance in some of the patients, and with hyperlipidaemia.
Journal ArticleDOI

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study.

TL;DR: 25(OH)D deficiency was frequent in HIV-infected persons (83% on combined antiretroviral therapy), and was independently associated with a higher risk of mortality and AIDS events.